Founded in 1993, ACGT is a DNA sequencing and molecular biology provider with services in high throughput Sanger sequencing, NGS and genomics, bioinformatics, genotyping, qPCR, cDNA library construction and more. With two locations in the Chicago north suburbs and the Washington, D.C. metro area, our facilities are CLIA accredited by the College of American Pathologists (CAP) and our services are offered at a standard research level, regulatory GLP or cGMP compliant, and clinical grade. Our clientele consists of life science researchers from academic institutions, biotech companies and drug developers and public health agencies. For more information visit us at www.acgtinc.com or you may contact us at 1.800.557.2248.
Charles River Labs has acquired Pathoquest, strengthening its end-to-end biologics testing portfolio with Next Generation Sequencing (NGS). Our GMP-compliant, animal-free NGS assays for viral safety and genetic characterization enable a faster and safer release of biotherapies to patients.
Pathoquest, A Charles River Company, is a global CRO specializing in NGS-based Biosafety Quality Control through its iDTECT® assay platform, enabling the rapid and safe release of biotherapies to patients. The company offers validated GMP assays for viral safety testing and genetic characterization of raw materials, cell and gene therapies, monoclonal antibodies, and vaccines. Our testing services are available from facilities located in Paris, France, and Wayne, Pennsylvania.
Your GMP Next-Gen Biosafety Partner. Compliant, Faster, Animal-Free.
@NRGene applies innovative cloud-based-#genomics and data-driven insights to optimize natural resources for #foodsecurity and #sustainable #agriculture
Visit our website for more information